Boston Scientific Corporation BSX

43.92 (0.76) (1.70%) as of 25 Sep
Market cap
$64.7B
P/E
17.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
48.65 70.89 54.06 102.24 61.57 0.00 13.38 29.21 316.00 84.15
P/S ratio
7.03 7.85 5.90 5.19 5.08 5.14 5.86 4.97 3.83 3.54
P/FCF ratio
38.59 49.69 46.90 69.28 45.43 44.52 45.53 6,100.57 31.29 35.57
P/Operating CF
103.49 90.27 87.82 81.56 126.40 75.68 90.93 2,568.66 50.64 43.94
P/B ratio
5.77 5.97 4.30 3.75 3.63 3.32 4.53 5.59 4.94 4.41
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
7.50 8.47 6.48 5.82 5.68 5.89 6.77 5.67 4.43 4.17
EV/EBITDA
29.97 33.28 25.65 25.33 25.39 36.99 47.93 37.00 31.18 78.28
EV/Operating CF
33.22 41.27 36.87 48.38 36.13 38.69 39.60 179.72 28.10 29.60
EV/FCF
41.18 53.60 51.49 77.71 50.80 51.00 52.62 6,964.32 36.19 41.91
Quick Ratio
0.90 0.46 0.63 0.76 0.87 0.89 0.42 0.33 0.31 0.47
Current Ratio
1.62 1.08 1.32 1.51 1.48 1.82 0.97 0.76 0.68 0.90
Net Debt/EBITDA
1.88 2.43 2.29 2.75 2.68 4.70 3.72 2.84 2.54 4.15
Debt/Assets
26.19% 27.28% 25.91% 27.52% 28.13% 29.71% 32.74% 33.60% 29.49% 30.31%
Debt/Equity
0.47 0.49 0.47 0.51 0.55 0.60 0.72 0.81 0.80 0.81
Asset Turnover
0.48 0.45 0.42 0.39 0.38 0.32 0.42 0.49 0.49 0.46
Operating CF/Net income
1.56 1.85 1.59 2.38 1.90 (13.11) 0.39 0.19 13.71 3.41
Capex/Depreciation
(0.62) (0.48) (0.57) (0.45) (0.37) (0.22) (0.41) (0.33) (0.38) (0.42)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
12.47% 8.92% 8.46% 3.75% 6.17% (0.79%) 41.59% 21.24% 1.51% 5.32%
ROA
6.98% 4.97% 4.64% 1.98% 3.13% (0.37%) 18.23% 8.35% 0.56% 1.92%
ROIC
6.65% 5.04% 5.27% 4.02% 3.15% (0.22%) 4.01% 6.02% 6.46% 2.32%
Return on Tangible Assets
39.21% 48.57% 35.36% 14.58% 22.93% (2.26%) 245.82% 318.29% (77.04%) 27.07%
Average Days of Receivables
53.20 55.75 57.11 56.70 54.59 56.37 62.15 59.75 62.45 64.07
Research and Development Expense of Revenue
10.22% 9.64% 9.93% 10.43% 10.13% 11.53% 10.94% 11.33% 11.02% 10.97%
Selling, General and Administrative Expense of Revenue
34.54% 35.93% 36.77% 36.01% 37.08% 38.66% 37.32% 37.05% 37.16% 37.90%
Intangible Assets out of Total Assets
0.58 0.60 0.58 0.58 0.56 0.52 0.59 0.68 0.67 0.69
Share Based Compensation of Revenue
1.49% 1.59% 1.64% 1.73% 1.63% 1.71% 1.46% 1.43% 1.40% 1.38%
Graham Net Nets
(0.07) (0.08) (0.11) (0.14) (0.15) (0.17) (0.19) (0.17) (0.24) (0.27)
Graham Number
27.00 20.59 17.99 11.15 13.47 0.00 27.54 13.12 3.03 5.39
Earnings Yield
2.06% 1.41% 1.85% 0.98% 1.62% (0.34%) 7.47% 3.42% 0.32% 1.19%
Free Cash Flow Yield
2.59% 2.01% 2.13% 1.44% 2.20% 2.25% 2.20% 0.02% 3.20% 2.81%
Revenue per Share
13.56 11.38 9.80 8.87 8.36 7.00 7.71 7.11 6.60 6.18
Operating CF per Share
3.06 2.33 1.72 1.07 1.31 1.06 1.32 0.22 1.04 0.87
Capex per Share
(0.59) (0.54) (0.49) (0.40) (0.38) (0.26) (0.33) (0.22) (0.23) (0.26)
Free Cash Flow per Share
2.47 1.80 1.23 0.66 0.94 0.81 0.99 0.01 0.81 0.62
Cash per Share
1.33 0.28 0.60 0.65 1.35 1.22 0.16 0.11 0.14 0.14
Shareholders Equity per Share
16.53 14.95 13.44 12.28 11.69 10.82 9.97 6.32 5.12 4.96
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
16.53 14.95 13.44 12.28 11.69 10.82 9.97 6.32 5.12 4.96
Free Cash Flow
3,658.00 2,645.00 1,792.00 950.00 1,330.00 1,144.00 1,382.00 8.00 1,107.00 835.00
Working Capital
3,355.00 521.00 1,581.00 1,957.00 2,043.00 3,013.00 (167.00) (1,257.00) (1,832.00) (348.00)
Capital Expenditures
(876.00) (790.00) (711.00) (576.00) (540.00) (364.00) (454.00) (302.00) (319.00) (347.00)
Net Current Asset Value
(10,407.00) (10,472.00) (9,092.00) (9,136.00) (9,290.00) (8,757.00) (11,989.00) (8,270.00) (8,208.00) (8,124.00)
EV/EBIT
41.70 54.42 39.38 44.82 56.39 0.00 47.93 37.00 31.18 78.28
Capex to Sales
0.04 0.05 0.05 0.05 0.05 0.04 0.04 0.03 0.04 0.04
Net Profit Margin
14.44% 11.06% 11.03% 5.06% 8.29% (1.16%) 43.78% 17.01% 1.15% 4.14%
Price to Operating Income
39.08 50.45 35.87 39.96 50.43 0.00 41.48 32.41 26.95 66.45
Other line items
Depreciation/Fixed assets
0.35 0.50 0.44 0.52 0.65 0.79 0.54 0.52 0.50 0.51
Cash ROIC
1.31% 0.43% (1.21%) (3.35%) (1.38%) (2.20%) (1.01%) (9.24%) (2.11%) (3.61%)
Accounts Receivable Turnover
7.32 7.00 6.78 6.77 7.19 5.90 6.25 6.23 5.99 6.11
Accounts Payable Turnover
5.91 5.53 4.82 4.78 5.68 6.57 6.99 6.40 5.31 7.39
Inventory Turnover
2.16 1.99 2.00 2.28 2.51 2.37 2.27 2.51 2.55 2.46
Average Days of Payables
67.12 66.65 79.13 79.53 78.09 54.04 63.49 45.28 74.60 67.31
Days of Inventory on Hand
172.67 195.10 208.67 172.26 158.35 142.31 184.96 151.29 151.74 143.80
Average Receivables
2,742.00 2,393.00 2,099.00 1,874.00 1,654.50 1,679.50 1,718.00 1,578.00 1,510.00 1,373.50
Average Payables
1,052.00 951.00 902.00 828.00 653.50 527.50 445.50 439.50 488.50 328.00
Average Inventory
2,876.50 2,647.00 2,175.50 1,738.50 1,480.50 1,465.00 1,372.50 1,122.00 1,016.50 985.50
Average Assets
41,534.00 37,265.50 33,802.50 32,349.00 31,503.00 30,671.00 25,782.00 20,020.50 18,569.00 18,114.50
Average Common Equity
23,237.00 20,766.00 18,551.50 17,098.50 15,975.00 14,602.00 11,301.00 7,868.00 6,872.00 6,526.50

Fold the line items

Columns are period end dates